英文摘要 |
The disease associated with antibodies against myelin oligodendrocyte glycoprotein (MOG) is a critical and potentially fatal condition. It progresses rapidly, lacks specificity in clinical presentation, and is challenging to diagnose. Without timely and accurate diagnosis and treatment, it can significantly impact the patient's future life. This case study explores a 48-year-old female presenting with recurrent limb weakness, limb numbness, and expressive aphasia. A comprehensive assessment was conducted using detailed medical history, physical examination, relevant laboratory tests, and imaging studies, including multiple magnetic resonance imaging scans. The patient was suspected to have an inflammatory or demyelinating disorder, received intravenous pulse high-dose corticosteroid therapy, and was ultimately diagnosed with a case of disease related to antibodies against myelin oligodendrocyte glycoprotein. This case report aims to share insights for clinical healthcare professionals to understand the progression and care associated with this disease, ultimately reducing the occurrence of disability and impairment. It is recommended that future medical education and care-sharing initiatives in specialized fields should focus on enhancing awareness of this disease, thereby improving the quality of healthcare and overall quality of life. |